32 related articles for article (PubMed ID: 37318056)
1. Arginine-Enhanced Antimicrobial Activity of Nanozymes against Gram-Negative Bacteria.
Zhao Z; Wen S; Song N; Wang L; Zhou Y; Deng X; Wu C; Zhang G; Chen J; Tian GB; Liang M; Zhong LL
Adv Healthc Mater; 2024 Feb; 13(4):e2301332. PubMed ID: 37924312
[TBL] [Abstract][Full Text] [Related]
2. Cetyltrimethylammonium-chloride assisted in situ metabolic incorporation of nano-sized ROS-generating cascade-reaction containers in Gram-positive and Gram-negative peptidoglycan layers for the control of bacterially-induced sepsis.
Yang G; Wang DY; Song J; Ren Y; An Y; Busscher HJ; van der Mei HC; Shi L
Acta Biomater; 2024 Jun; 181():347-361. PubMed ID: 38702010
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Cascade Catalytic Glutathione-Depleting MOF Nanoreactors.
Zhou X; Zhang S; Liu Y; Meng J; Wang M; Sun Y; Xia L; He Z; Hu W; Ren L; Chen Z; Zhang X
ACS Appl Mater Interfaces; 2022 Mar; 14(9):11104-11115. PubMed ID: 35199514
[TBL] [Abstract][Full Text] [Related]
4. The Molecular Mechanisms of the Antibacterial Effect of Picosecond Laser Generated Silver Nanoparticles and Their Toxicity to Human Cells.
Korshed P; Li L; Liu Z; Wang T
PLoS One; 2016; 11(8):e0160078. PubMed ID: 27575485
[TBL] [Abstract][Full Text] [Related]
5. Copper/Carbon Hybrid Nanozyme: Tuning Catalytic Activity by the Copper State for Antibacterial Therapy.
Xi J; Wei G; An L; Xu Z; Xu Z; Fan L; Gao L
Nano Lett; 2019 Nov; 19(11):7645-7654. PubMed ID: 31580681
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species-mediated CuRuO
Guo J; Zhang X; Yang Y; Zhu X; Chen X; Ye G; Liu J
J Mater Chem B; 2023 Jun; 11(23):5195-5206. PubMed ID: 37266688
[TBL] [Abstract][Full Text] [Related]
7. Nanozyme-based guanidinium peptides mediate surface reactive oxygen species for multidrug resistant bacterial infection management.
Zhu X; Sun Q; Chen J; Liang C; Chen L; Qi Y; Luo H; Chen L; Chen J
J Mater Chem B; 2023 Jul; 11(27):6393-6403. PubMed ID: 37338269
[TBL] [Abstract][Full Text] [Related]
8. Ir(IV) and Ir(III)
Zhu X; Yang Y; Chen X; Ye G; Liu J; Liu Y
Biomater Sci; 2023 Jul; 11(14):4960-4971. PubMed ID: 37318056
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
10. Nanozymes used for antimicrobials and their applications.
Yang D; Chen Z; Gao Z; Tammina SK; Yang Y
Colloids Surf B Biointerfaces; 2020 Nov; 195():111252. PubMed ID: 32679446
[TBL] [Abstract][Full Text] [Related]
11. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
[TBL] [Abstract][Full Text] [Related]
12. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
